United Kingdom

People: OncoTherapy Science Inc (4564.T)

4564.T on Tokyo Stock Exchange

3:28am BST
Change (% chg)

¥0 (+0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chung, Suyoun 

Ms. Suyoun Chung was named Director of Clinical Development and Director in OncoTherapy Science, Inc. effective January 12, 2019. She was also named President and Representative Director in OncoTherapy Science, Inc. effective November 30, 2018. She joined the Company in April 2015. She previously served as Executive Officer in the Company. She used to work for National Cancer Center Research Institute and University of Chicago, the United States. She obtained her Ph.D. in Life Science from University of Tokyo in March 2011.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --